GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Venus Concept Inc (NAS:VERO) » Definitions » ROC (Joel Greenblatt) %

VERO (Venus Concept) ROC (Joel Greenblatt) % : -100.43% (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Venus Concept ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Venus Concept's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was -100.43%.

The historical rank and industry rank for Venus Concept's ROC (Joel Greenblatt) % or its related term are showing as below:

VERO' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -643.22   Med: -154.08   Max: -38.1
Current: -112.82

During the past 9 years, Venus Concept's highest ROC (Joel Greenblatt) % was -38.10%. The lowest was -643.22%. And the median was -154.08%.

VERO's ROC (Joel Greenblatt) % is ranked worse than
71.06% of 850 companies
in the Medical Devices & Instruments industry
Industry Median: -0.525 vs VERO: -112.82

Venus Concept's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 32.30% per year.


Venus Concept ROC (Joel Greenblatt) % Historical Data

The historical data trend for Venus Concept's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Venus Concept ROC (Joel Greenblatt) % Chart

Venus Concept Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only -125.51 -154.08 -38.10 -85.23 -68.76

Venus Concept Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -64.01 -83.93 -78.38 -203.08 -100.43

Competitive Comparison of Venus Concept's ROC (Joel Greenblatt) %

For the Medical Devices subindustry, Venus Concept's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Venus Concept's ROC (Joel Greenblatt) % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Venus Concept's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Venus Concept's ROC (Joel Greenblatt) % falls into.



Venus Concept ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(24.584 + 19.782 + 6.011) - (21.428 + 2.092 + 0)
=26.857

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(21.102 + 18.904 + 6.026) - (19.529 + 1.942 + 0)
=24.561

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Venus Concept for the quarter that ended in Sep. 2024 can be restated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-30.672/( ( (5.033 + max(26.857, 0)) + (4.629 + max(24.561, 0)) )/ 2 )
=-30.672/( ( 31.89 + 29.19 )/ 2 )
=-30.672/30.54
=-100.43 %

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Venus Concept  (NAS:VERO) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Venus Concept ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Venus Concept's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Venus Concept Business Description

Traded in Other Exchanges
N/A
Address
235 Yorkland Boulevard, Suite 900, Toronto, ON, CAN, M2J 4Y8
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.
Executives
Anthony Natale director 235 YORKLAND BLVD., SUITE 900, TORONTO A6 M2J 4Y8
Michael Willingham Masters 10 percent owner 3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305
Ross Portaro officer: President Global Sales 235 YORKLAND BLVD, SUITE 900, TORONTO Z4 M2J 4Y8
Masters Special Situations, Llc 10 percent owner 3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305
Mss Vc Spv Lp 10 percent owner C/O MASTERS SPECIAL SITUATIONS, LLC, 3060 PEACHTREE ROAD, NW, STE.1425, ATLANTA GA 30305
Marlin Fund Iii, Limited Partnership 10 percent owner MASTERS CAPITAL MANAGEMENT, LLC, 3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305
Marlin Fund Ii, Limited Partnership 10 percent owner MASTERS CAPITAL MANAGEMENT, LLC, 3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305
Masters Capital Management Llc 10 percent owner 3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305
Marlin Fund, Limited Partnership 10 percent owner MASTERS CAPITAL MANAGEMENT, LLC, 3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305
Silva Rajiv De director, officer: Chief Executive Officer 1400 ATWATER DRIVE, MALVERN PA 19355
Marlin Master Fund Offshore Ii, Lp 10 percent owner WAYSTONE CORP SV (CAYMAN) LTD, STE 5B201, FL 2, 1 NEXUS WAY, CAMANA BAY, BOX 1344, GRAND CAYMAN E9 KY1-1108
Hemanth Jacob Varghese officer: President/Chief Bus. Officer 330 JOICEY BOULEVARD, TORONTO A6 M5M2W1
Stanley Tyler Hollmig director 235 YORKLAND BLVD, SUITE 900, TORONTO Z4 M2J 4Y8
Penna Domenic Della officer: Chief Financial Officer 235 YORKLAND BLVD., SUITE 900, TORONTO A6 M2J 4Y8
Anna Georgiadis officer: VP, Global HR 235 YORKLAND BLVD., SUITE 900, TORONTO A6 M2J 4Y8